Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study
Clinical trial NCT03105375 · COMPLETED
Trial details
- NCT number
- NCT03105375
- Sponsor
- Cinclus Pharma Holding AB
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2017-10-12
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.